Direct oral anticoagulants versus warfarin among atrial fibrillation patients with chronic kidney disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Direct Oral Anticoagulants Versus Warfarin Among Atrial Fibrillation Patients With Chronic Kidney Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305238/all/images/closex.png.
Direct oral anticoagulants versus warfarin among atrial fibrillation patients with chronic kidney disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305238/all/images/closex.png. Accessed April 30, 2024.
Direct oral anticoagulants versus warfarin among atrial fibrillation patients with chronic kidney disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305238/all/images/closex.png
Direct Oral Anticoagulants Versus Warfarin Among Atrial Fibrillation Patients With Chronic Kidney Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305238/all/images/closex.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Direct oral anticoagulants versus warfarin among atrial fibrillation patients with chronic kidney disease
ID - 1305238
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305238/all/images/closex.png
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -